A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

Suzetrigine and the opioid treatment both cut pain by about ... Among trial participants, the most common side effects of the drug were itching, muscle spasms, increased levels of creatine ...

Vertex Pharmaceuticals ( VRTX 2.53%) has long been known as the company to turn to for life-saving cystic fibrosis (CF) drugs ...

Nearly 22,000 pounds of fentanyl were seized at US borders during the 2024 fiscal year, according to data from the US Customs ...

"This policy aims to improve access and affordability, ensuring suzetrigine’s inclusion in outpatient and surgical settings while reducing reliance on opioids," he said. The most common side ...

In a national sample, around one-third of college students knew what the most common opioid reversal agent was, but fewer than 15% knew how to use it. Encouragingly, more than two-thirds said they ...

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side effects.

Virginia Tech researchers surveyed 350 people and found painkillers followed by opioids like fentanyl required the most ...

the most common side effects experienced by study participants after taking Journavx included muscle spasms, itching, and rashes. Suzetrigine belongs to a new class of non-opioid pain medications ...

In a recent study, majority non-White communities had at least 40 percent lower mean adjusted per-capita distribution than majority White communities.